| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) |
|
12090.35 | 118.55 | 0.99% |
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Avexa Ltd (ASX: AVX)
AVX Technical Analysis
1.5
| As on 9th Dec 2016 AVX Share Price closed @ 0.03 and we RECOMMEND Sell for LONG-TERM with Stoploss of 0.03 & Buy for SHORT-TERM with Stoploss of 0.03 we also expect STOCK to react on Following IMPORTANT LEVELS. |
AVX Share Price
| Open | 0.03 | Change | Price | % |
| High | 0.03 | 1 Day | 0.00 | 0.00 |
| Low | 0.03 | 1 Week | 0.00 | 0.00 |
| Close | 0.03 | 1 Month | 0.00 | 0.00 |
| Volume | 121428 | 1 Year | 0.00 | 0.00 |
| 52 Week High 0.03 | 52 Week Low 0.02 | ||||
ASX Australia Most Active Stocks
| COE | 0.30 | 3.45% |
| GPP | 0.02 | 0.00% |
| DUE | 3.02 | 1.00% |
| BUR | 0.02 | 0.00% |
| AGO | 0.02 | 0.00% |
| BPT | 1.05 | 7.14% |
| PNX | 0.01 | 0.00% |
| PIO | 0.03 | 0.00% |
| DJS | 3.99 | 0.00% |
| KSO | 0.40 | 3900.00% |
ASX Australia Top Gainers Stocks
ASX Australia Top Losers Stocks
| AVX Daily Charts |
AVX Intraday Charts |
Whats New @ Bazaartrend |
AVX Free Analysis |
|
|
AVX Important Levels Intraday
| SUPPORT | 0.00 |
| SUPPORT | 0.00 |
| RESISTANCE | 0.03 |
| RESISTANCE | 0.03 |
| RESISTANCE | 0.03 |
| RESISTANCE | 0.03 |
| SUPPORT | 0.00 |
| SUPPORT | 0.00 |
AVX Target for Month December
| 4th UP TARGET | 0 |
| 3rd UP TARGET | 0 |
| 2nd UP TARGET | 0 |
| 1st UP TARGET | 0 |
| 1st DOWN TARGET | 0 |
| 2nd DOWN TARGET | 0 |
| 3rd DOWN TARGET | 0 |
| 4th DOWN TARGET | 0 |
AVX Weekly Target
| 4th UP TARGET | 0.00 |
| 3rd UP TARGET | 0.00 |
| 2nd UP TARGET | 0.00 |
| 1st UP TARGET | 0.00 |
| 1st DOWN TARGET | 0.00 |
| 2nd DOWN TARGET | 0.00 |
| 3rd DOWN TARGET | 0.00 |
| 4th DOWN TARGET | 0.00 |
AVX Target for Year 2019
| 4th UP TARGET | 0 |
| 3rd UP TARGET | 0 |
| 2nd UP TARGET | 0 |
| 1st UP TARGET | 0 |
| 1st DOWN TARGET | 0 |
| 2nd DOWN TARGET | 0 |
| 3rd DOWN TARGET | 0 |
| 4th DOWN TARGET | 0 |
Avexa Ltd ( ASX Australia Symbol : AVX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
AVX Other Details
| Segment | EQ | |
| Market Capital | 0.00 | |
| Sector | Healthcare | |
| Industry | Biotechnology | |
| Offical website | http://www.avexa.com.au | |
AVX Address
 |
61-63 Camberwell Road Level 1 Hawthorn East, VIC 3123 Australia Phone: 61 3 9208 4300 Fax: 61 3 9208 4146 |
|
AVX Latest News
AVX Business Profile
Avexa Limited, a biotechnology company, discovers and develops anti-infective pharmaceutical medicines for the treatment of human infectious diseases. The companyÂ’s research programs primarily focus on the discovery of medicines for the treatment of the diseases caused by human immunodeficiency virus (HIV) and vancomycin-and methicillin-resistant bacteria. Its primary project includes apricitabine (ATC) for the treatment of drug resistant HIV, an HIV integrase program and an antibiotic program for antibiotic-resistant bacterial infections. The company was founded in 2004 and is based in Hawthorn East, Australia.
© 2005-2019 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
